|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7-8
|
|
pubmed:dateCreated |
2001-6-21
|
|
pubmed:abstractText |
Tetrahydrobiopterin (BH4) is a regulatory cofactor for the activity of nitric oxide synthases. Vasodilating properties of BH4 have been reported in vitro and in vivo. The influence of BH4 on myocardial blood flow (MBF), however, is largely unknown. We therefore performed a double-blind, placebo-controlled study to investigate the effect of intravenous BH4 on MBF in healthy volunteers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1424-7860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
24
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
91-4
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11416883-Adult,
pubmed-meshheading:11416883-Biopterin,
pubmed-meshheading:11416883-Coronary Circulation,
pubmed-meshheading:11416883-Double-Blind Method,
pubmed-meshheading:11416883-Electrocardiography,
pubmed-meshheading:11416883-Female,
pubmed-meshheading:11416883-Heart,
pubmed-meshheading:11416883-Humans,
pubmed-meshheading:11416883-Injections, Intravenous,
pubmed-meshheading:11416883-Male,
pubmed-meshheading:11416883-Reference Values,
pubmed-meshheading:11416883-Sensitivity and Specificity,
pubmed-meshheading:11416883-Tomography, Emission-Computed
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Tetrahydrobiopterin increases myocardial blood flow in healthy volunteers: a double-blind, placebo-controlled study.
|
|
pubmed:affiliation |
Department of Medicine, Medical Clinic B Research Unit, University Hospital of Zürich, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
